Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer
Open accessThe DOI matches its Crossref record; 25 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In 1976, we initiated a randomized trial to determine whether lumpectomy with or without radiation therapy was as effective as total mastectomy for the treatment of invasive breast cancer. METHODS: A total of 1851 women for whom follow-up data were available and nodal status was known underwent randomly assigned treatment consisting of total mastectomy, lumpectomy alone, or lumpectomy and breast irradiation. Kaplan-Meier and cumulative-incidence estimates of the outcome were obtained. RESULTS: The cumulative incidence of recurrent tumor in the ipsilateral breast was 14.3 percent in the women who underwent lumpectomy and breast irradiation, as compared with 39.2 percent in the women who underwent lumpectomy without irradiation (P<0.001). No significant differences were observed among the three groups of women with respect to disease-free survival, distant-disease-free survival, or overall survival. The hazard ratio for death among the women who underwent lumpectomy alone, as compared with those who underwent total mastectomy, was 1.05 (95 percent confidence interval, 0.90 to 1.23; P=0.51). The hazard ratio for death among the women who underwent lumpectomy followed by breast irradiation, as compared with those who underwent total mastectomy, was 0.97 (95 percent confidence interval, 0.83 to 1.14; P=0.74). Among the lumpectomy-treated women whose surgical specimens had tumor-free margins, the hazard ratio for death among the women who underwent postoperative breast irradiation, as compared with those who did not, was 0.91 (95 percent confidence interval, 0.77 to 1.06; P=0.23). Radiation therapy was associated with a marginally significant decrease in deaths due to breast cancer. This decrease was partially offset by an increase in deaths from other causes. CONCLUSIONS: Lumpectomy followed by breast irradiation continues to be appropriate therapy for women with breast cancer, provided that the margins of resected specimens are free of tumor and an acceptable cosmetic result can be obtained.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This has resulted in improved outcomes in a number of different cancers (2, 342–350).”
From Adrenocortical carcinoma (2014) · cites this paper as [344]
In the citing paper
“Breast-conserving surgery combined with radiation therapy is standard treatment for early stage breast cancer and provides equivalent survival to mastectomy [20-27].”
From Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature (2010) · cites this paper as [20]
In the citing paper
“and it can be greatly reduced by radiotherapy. 4,5”
In the citing paper
“The risk of recurrence in a conserved breast can be substantial even in node-negative disease that has been confirmed by axillary clearance”
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181 · cited 1×
“Any first recurrence «5 yr >5 and «10 yr >10 yr 161 (74) 38 (17) 20 (9) 187 (70) 55 (20) 27 (10) 133 (62) 49 (23) 32 (15) 481 (69) 142 (20) 79 (11) Local «5 yr >5 and «10 yr >10 yr 47 (78) 9 (15) 4 (7) 43 (77) 10 (18) 3 (5) 5 (29) 7 (41) 5 (29) 95 (71) 26 (20) 12 (9) Regional «5 yr >5 and «10 yr >10 yr 24 (89) 2 (7) 1…”
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960 · cited 1×
“Any first recurrence «5 yr >5 and «10 yr >10 yr 161 (74) 38 (17) 20 (9) 187 (70) 55 (20) 27 (10) 133 (62) 49 (23) 32 (15) 481 (69) 142 (20) 79 (11) Local «5 yr >5 and «10 yr >10 yr 47 (78) 9 (15) 4 (7) 43 (77) 10 (18) 3 (5) 5 (29) 7 (41) 5 (29) 95 (71) 26 (20) 12 (9) Regional «5 yr >5 and «10 yr >10 yr 24 (89) 2 (7) 1…”
Veronesi, U., Cascinelli, N., Mariani, L., Greco, M., Saccozzi, R., Luini, A., Aguilar, M., & Marubini, E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020989 · Cited by 4,450
Asymptotically Efficient Rank Invariant Test Procedures
Peto, R., & Peto, J. (1972) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344317 · Cited by 3,393
Fisher, B., Bauer, M., Margolese, R., Poisson, R., Pilch, Y., Redmond, C., Fisher, E., Wolmark, N., Deutsch, M., Montague, E., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503143121101 · Cited by 2,194
Self-citationVeronesi, U., Saccozzi, R., Del Vecchio, M., Banfi, A., Clemente, C., De Lena, M., Gallus, G., Greco, M., Luini, A., Marubini, E., et al. (1981) · New England Journal of Medicine · doi:10.1056/nejm198107023050102 · Cited by 1,599
Research works printed but not linked: 4
- 10.2307/2281868 · doi:10.2307/2281868 · Paper page
- Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. In: Consensus development conference on the treatment of early-stage breast cancer. Journal of the National Cancer Institute monographs. No. 11. Bethesda, Md.: National Cancer Institute, 1992:19-25. (NIH publication no. 90-3187.)
- 10.1007/BF01655182 · DOI
- Veronesi U, 1983, Int Adv Surg Oncol, 6, 141
Cited by
Items 201–300 of 1,005
Impact of Micrometastases in the Sentinel Node of Patients With Invasive Breast Cancer
Hansen, N. M., Grube, B., Ye, X., Turner, R. R., Brenner, R. J., Sim, M.-S., & Giuliano, A. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.0686 · Cited by 166
Predictors of Surgical Margin Status in Breast-Conserving Surgery Within a Breast Screening Program
Kurniawan, E. D., Wong, M. H., Windle, I., Rose, A., Mou, A., Buchanan, M., Collins, J. P., Miller, J. A., Gruen, R. L., & Mann, G. B. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0054-4 · Cited by 163
Lagendijk, M., van Maaren, M. C., Saadatmand, S., Strobbe, L. J. A., Poortmans, P. M. P., Koppert, L. B., Tilanus‐Linthorst, M. M. A., & Siesling, S. (2018) · International Journal of Cancer · doi:10.1002/ijc.31034 · Cited by 159
Kruper, L., Holt, A., Xu, X. X., Duan, L., Henderson, K., Bernstein, L., & Ellenhorn, J. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1580-z · Cited by 161
“For women with early-stage breast cancer, randomized trials have demonstrated no difference in overall survival for women treated with a total mastectomy versus breast-conserving therapy (BCT).(2,3) Currently in the US, the majority of women (57.”
BackgroundMajor, T., Gutiérrez, C., Guix, B., van Limbergen, E., Strnad, V., & Polgár, C. (2016) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.12.006 · Cited by 163
“Furthermore, the majority of local recurrences occur in close proximity to the tumour bed [12,14,18,32,51,55].”
BackgroundMRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883
Schnall, M. D., Blume, J., Bluemke, D. A., DeAngelis, G. A., DeBruhl, N., Harms, S., Heywang-Köbrunner, S. H., Hylton, N., Kuhl, C. K., Pisano, E. D., et al. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20381 · Cited by 165
“The age of the population may be lower than the median age for a women with a new diagnosis of breast cancer [15].”
BackgroundEvidence of Poorer Survival in Pregnancy-Associated Breast Cancer
Rodriguez, A. O., Chew, H., Cress, R., Xing, G., McElvy, S., Danielsen, B., & Smith, L. (2008) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31817c4ebc · Cited by 163
de Bock, G. H., van der Hage, J. A., Putter, H., Bonnema, J., Bartelink, H., & van de Velde, C. J. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.10.006 · Cited by 165
“with a higher risk of loco-regional recurrence, compared with mastectomy [4–8].”
BackgroundFirst international consensus guidelines for breast cancer in young women (BCY1)
Partridge, A. H., Pagani, O., Abulkhair, O., Aebi, S., Amant, F., Azim, H. A., Costa, A., Delaloge, S., Freilich, G., Gentilini, O. D., et al. (2014) · The Breast · doi:10.1016/j.breast.2014.03.011 · Cited by 159
The process of metastasisation for breast cancer
Engel, J., Eckel, R., Kerr, J., Schmidt, M. K., Fürstenberger, G., Richter, R., Sauer, H., Senn, H.-J., & Hölzel, D. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00422-2 · Cited by 162
Caliskan, M., Gatti, G., Sosnovskikh, I., Rotmensz, N., Botteri, E., Musmeci, S., Rosali dos Santos, G., Viale, G., & Luini, A. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9880-5 · Cited by 162
“Breast conserving surgery and sentinel lymph node biopsy are the treatment of choice for most women with early-stage breast cancer [ 36 , 37].”
BackgroundEmerging role of MRI in radiation therapy
Chandarana, H., Wang, H., Tijssen, R. H. N., & Das, I. J. (2018) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26271 · Cited by 181
Neoadjuvant therapy for breast cancer
Liu, S. V., Melstrom, L., Yao, K., Russell, C. A., & Sener, S. F. (2010) · Journal of Surgical Oncology · doi:10.1002/jso.21446 · Cited by 162
“The NSABP B-41 trial will also examine lapatinib in a phase III study in which patients receive neoadjuvant AC and are then randomized to receive either lapatinib, trastuzumab, or both agents [34].”
MethodInfluentialSwanson, T., Grills, I. S., Ye, H., Entwistle, A., Teahan, M., Letts, N., Yan, D., Duquette, J., & Vicini, F. A. (2013) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e31823fe481 · Cited by 159
Trends in Racial and Age Disparities in Definitive Local Therapy of Early-Stage Breast Cancer
Freedman, R. A., He, Y., Winer, E. P., & Keating, N. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.9234 · Cited by 159
Analysis of local and regional recurrences in breast cancer after conservative surgery
Botteri, E., Bagnardi, V., Rotmensz, N., Gentilini, O., Disalvatore, D., Bazolli, B., Luini, A., & Veronesi, U. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp386 · Cited by 161
“However, local recurrence should not be considered as a failure of conservative approach or responsible for systemic progression by itself: previous randomized trials have shown that groups of patients with a high incidence of local recurrences have the same overall survival as that of patients with a low rate of loca…”
BackgroundMetaplastic Breast Cancer: To Radiate or Not to Radiate?
Tseng, W. H., & Martinez, S. R. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1198-6 · Cited by 161
Role of HER2 in wound-induced breast carcinoma proliferation
Tagliabue, E., Agresti, R., Carcangiu, M. L., Ghirelli, C., Morelli, D., Campiglio, M., Martel, M., Giovanazzi, R., Greco, M., Balsari, A., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14112-8 · Cited by 164
Hyperspectral imaging in medical applications
Fei, B. (2019) · Data handling in science and technology · doi:10.1016/b978-0-444-63977-6.00021-3 · Cited by 186
Vila, J., Gandini, S., & Gentilini, O. (2015) · The Breast · doi:10.1016/j.breast.2015.02.002 · Cited by 159
Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics
Kheirelseid, E. A. H., Jumustafa, H., Miller, N., Curran, C. E., Sweeney, K., Malone, C. M., McLaughlin, R., Newell, J., & Kerin, M. J. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1057-y · Cited by 157
“Finally, most studies have demonstrated no significant increase risk of contralateral breast cancer after radiation treatment for initial tumour [43-45], while others documented the opposite [46-48].”
BackgroundOsman, S. O. S., Hol, S., Poortmans, P. M., & Essers, M. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.04.004 · Cited by 159
“Radiation therapy (RT) has demonstrated clear clinical benefits for all patients treated with breast conserving therapy (BCT) and for patients after radical mastectomy with risk factors for relapses [1–4].”
BackgroundReimer, T., Stachs, A., Nekljudova, V., Loibl, S., Hartmann, S., Wolter, K., Hildebrandt, G., & Gerber, B. (2017) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0042-122853 · Cited by 157
“[50] (2002) NSABP B-04 All ages, cN0,MRMvs.”
Treatment of invasive breast carcinoma with ultrasound-guided radiofrequency ablation
Hayashi, A., Silver, S. F., van der Westhuizen, N. G., Donald, J. C., Parker, C., Fraser, S., Ross, A., & Olivotto, I. A. (2003) · The American Journal of Surgery · doi:10.1016/s0002-9610(03)00061-8 · Cited by 156
Determining the Optimal Approach to Breast Reconstruction after Partial Mastectomy
Kronowitz, S. J., Feledy, J. A., Hunt, K. K., Kuerer, H. M., Youssef, A., Koutz, C. A., & Robb, G. L. (2006) · Plastic & Reconstructive Surgery · doi:10.1097/01.prs.0000194899.01875.d6 · Cited by 156
Mortality Impact of Less-than-Standard Therapy in Older Breast Cancer Patients
Yood, M. U., Owusu, C., Buist, D. S. M., Geiger, A. M., Field, T. S., Thwin, S. S., Lash, T. L., Prout, M. N., Wei, F., Quinn, V. P., et al. (2008) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.07.015 · Cited by 155
Freedman, G. M., Anderson, P. R., Li, T., & Nicolaou, N. (2009) · Cancer · doi:10.1002/cncr.24094 · Cited by 155
Chakravorty, A., Shrestha, A., Sanmugalingam, N., Rapisarda, F., Roche, N., della Rovere, G. Q., & MacNeill, F. A. (2012) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2012.02.186 · Cited by 154
An approach to measuring the quality of breast cancer decisions
Sepucha, K., Ozanne, E. M., Silvia, K. A., Partridge, A. H., & Mulley, A. G. (2006) · Patient Education and Counseling · doi:10.1016/j.pec.2006.08.007 · Cited by 154
“For early stage invasive breast cancer, the equivalence of mastectomy and lumpectomy followed by radiation for overall survival and distant disease free survival has been demonstrated in large randomized controlled trials with long follow-up [1,2].”
BackgroundSelf‐Assembling Doxorubicin Silk Hydrogels for the Focal Treatment of Primary Breast Cancer
Seib, F. P., Pritchard, E. M., & Kaplan, D. L. (2012) · Advanced Functional Materials · doi:10.1002/adfm.201201238 · Cited by 153
Carlson, R. W., Allred, D. C., Anderson, B. O., Burstein, H. J., Carter, W. B., Edge, S. B., Erban, J. K., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0016 · Cited by 179
Hartmann-Johnsen, O. J., Kåresen, R., Schlichting, E., & Nygård, J. F. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4441-3 · Cited by 153
Poortmans, P. M., Collette, L., Horiot, J.-C., den Bogaert, W. F. V., Fourquet, A., Kuten, A., Noordijk, E. M., Hoogenraad, W. J., Mirimanoff, R., Piérart, M., et al. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.07.011 · Cited by 161
“Breast-conserving therapy (BCT) is considered the standard of care for stage I and II breast cancer patients, with equivalent survival compared to mastectomy [1–3].”
BackgroundDisparities in Breast Cancer Treatment and Survival for Women with Disabilities
McCarthy, E. P., Ngo, L. H., Roetzheim, R. G., Chirikos, T. N., Li, D., Drews, R. E., & Iezzoni, L. I. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-9-200611070-00005 · Cited by 151
“Clinical trials show that breast-conserving surgery and mastectomy have equal survival rates (2, 40, 41), and therefore, differences in treatment may not affect a woman’s prognosis.”
BackgroundHo, R. T. H., Fong, T. C. T., Cheung, I. K. M., Yip, P. S. F., & Luk, M.-Y. (2016) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2015.12.332 · Cited by 149
Aziz, D., Rawlinson, E., Narod, S. A., Sun, P., Lickley, H. L. A., McCready, D. R., & Holloway, C. M. B. (2006) · The Breast Journal · doi:10.1111/j.1075-122x.2006.00271.x · Cited by 149
“This has been established by several randomized controlled trials (1,2).”
MethodShah, C., Badiyan, S. N., Wilkinson, J. B., Vicini, F. A., Beitsch, P. D., Keisch, M. E., Arthur, D. W., & LYDEN, M. R. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3158-4 · Cited by 149
Hanson, S. E., Lei, X. J., Roubaud, M. S., DeSnyder, S. M., Caudle, A. S., Shaitelman, S. F., Hoffman, K. E., Smith, G. L., Jagsi, R., Peterson, S. K., et al. (2022) · JAMA Surgery · doi:10.1001/jamasurg.2022.0631 · Cited by 149
Chen, X., & Song, E. (2022) · 癌症:英文版 · doi:10.1002/cac2.12316 · Cited by 163
Broadening the view of evidence-based medicine
Berwick, D. M. (2005) · Quality and Safety in Health Care · doi:10.1136/qshc.2005.015669 · Cited by 149
Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society
Arthur, D. W., Vicini, F. A., Kuske, R. R., Wazer, D. E., & Nag, S. K. (2003) · Brachytherapy · doi:10.1016/s1538-4721(03)00107-7 · Cited by 149
Zippel, D. B., & Papa, M. Z. (2005) · Breast Cancer · doi:10.2325/jbcs.12.32 · Cited by 149
Rew, D. A. (2008) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2008.11.001 · Cited by 149
The History of Early Breast Cancer Treatment
Ben-Dror, J., Shalamov, M. M., & Sonnenblick, A. (2022) · Genes · doi:10.3390/genes13060960 · Cited by 167
“The clear effectiveness of breast radiation was first provided by the previously described NSABP B-06 trial, which showed that adding RT to lumpectomy could provide a means to spare women to avoid mastectomy [3].”
BackgroundMethodTrends in Radiation Therapy among Cancer Survivors in the United States, 2000–2030
Bryant, A. K., Banegas, M. P., Martínez, M. E., Mell, L. K., & Murphy, J. D. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-1023 · Cited by 149
First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity
Vicini, F. A., Beitsch, P. D., Quiet, C. A., Keleher, A. J., Garcia, D. M., Snider, H. C., Gittleman, M. A., Zannis, V. J., Kuerer, H. M., Whitacre, E. B., et al. (2005) · Cancer · doi:10.1002/cncr.21289 · Cited by 147
“cinoma has been demonstrated in several Phase III trials with long-term follow-up.(1,2) Despite the effi-”
BackgroundKroman, N. T., Holtveg, H., Wohlfahrt, J., Jensen, M., Mouridsen, H. T., Blichert-Toft, M., & Melbye, M. (2004) · Cancer · doi:10.1002/cncr.20022 · Cited by 146
“Breast-conserving therapy (BCT), in which surgery is restricted to removal of the clinically apparent tumor, generally is accepted as a treatment whose effectiveness is equal to that of modified radical mastectomy (RM) in early-stage breast carcinoma.(1,2) Nonetheless, this conclusion is based primarily on data from m…”
BackgroundResultGoodman, C. R., Seagle, B.-L. L., Friedl, T. W. P., Rack, B., Lato, K., Fink, V., Cristofanilli, M., Donnelly, E. D., Janni, W., Shahabi, S., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.0163 · Cited by 143
Implementation of Value Based Breast Cancer Care
van Egdom, L. S. E., Lagendijk, M., van der Kemp, M. H., van Dam, J. H., Mureau, M. A. M., Hazelzet, J. A., & Koppert, L. B. (2019) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2019.01.007 · Cited by 145
Jibaja‐Weiss, M. L., Volk, R. J., Granchi, T. S., Neff, N. E., Robinson, E. K., Spann, S. J., Aoki, N., Friedman, L. C., & Beck, J. R. (2010) · Patient Education and Counseling · doi:10.1016/j.pec.2010.06.009 · Cited by 151
“Breast-conserving surgery (BCS) is a well-established alternative to mastectomy (MT) for women with early stage breast cancer [1].”
BackgroundAlpert, T. E., Kuerer, H. M., Arthur, D. W., Lannin, D. R., & Haffty, B. G. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.02.035 · Cited by 142
Blair, S. L., Thompson, K., Rococco, J., Malcarne, V. L., Beitsch, P. D., & Ollila, D. W. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.07.026 · Cited by 142
Zdenkowski, N., Butow, P. N., Tesson, S., & Boyle, F. M. (2016) · The Breast · doi:10.1016/j.breast.2015.12.007 · Cited by 151
Al‐Hilli, Z., & Wilkerson, A. D. (2021) · Surgical Clinics of North America · doi:10.1016/j.suc.2021.06.014 · Cited by 159
Radiation Therapy for Early-Stage Breast Cancer after Breast-Conserving Surgery
Buchholz, T. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmct0803525 · Cited by 141
Vicini, F. A., Winter, K. A., Straube, W. L., Wong, J. W., Pass, H. A., Rabinovitch, R. A., Chafe, S., Arthur, D. W., Petersen, I. A., & McCormick, B. L. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.06.024 · Cited by 141
Quantitative, spectrally-resolved intraoperative fluorescence imaging
Valdés, P. A., Leblond, F., Jacobs, V. L., Wilson, B. C., Paulsen, K. D., & Roberts, D. W. (2012) · Scientific Reports · doi:10.1038/srep00798 · Cited by 130
“A total of nine (9) phantoms of three (3) different optical absorption (ma,x 5 20, 40, and 60 cm(21)) and scattering values (m’s,m 5 8.”
BackgroundOutcome and prognostic factors in breast sarcoma: A multicenter study from the rare cancer network
Bousquet, G., Confavreux, C. B., Magné, N., de Lara, C. T., Poortmans, P., Senkus, E., de Lafontan, B., Bolla, M., Largillier, R., Lagneau, E., et al. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.10.015 · Cited by 140
Ott, O. J., Hildebrandt, G., Pötter, R., Hammer, J., Lotter, M., Resch, A., Sauer, R., & Strnad, V. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.08.028 · Cited by 139
“Analysis of the 20-year results of the NSABP B-06 protocol [7] clearly indicates that whole breast irradiation can impressively reduce the incidence of in-breast recurrences during the first 5 years of follow-up.”
BackgroundApplicability and safety of autologous fat for reconstruction of the breast
Claro, F., de Figueiredo, J. C. A., Zampar, A. G., & Pinto-Neto, A. M. (2012) · British journal of surgery · doi:10.1002/bjs.8722 · Cited by 143
Olive oil oleuropein has anti-breast cancer properties with higher efficiency on ER-negative cells
Elamin, M. H., Daghestani, M. H., Omer, S. A., Elobeid, M., Virk, P., Al-Olayan, E. M., Hassan, Z. K., Mohammed, O. B., & Aboussekhra, A. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.12.009 · Cited by 138
“However, breast-conserving surgery followed by whole-breast irradiation, has become the standard of care in the treatment of early-stage breast cancer (Fisher et al., 2002; Clarke et al., 2005).”
BackgroundStrnad, V., Hannoun‐Lévi, J., Guinot, J. L., Lössl, K., Kauer-Dorner, D., Resch, A., Kovács, G., Major, T., & Limbergen, E. V. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.06.010 · Cited by 138
Mannino, M., & Yarnold, J. R. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.05.002 · Cited by 138
“Of 16 randomised trials [6–10,34,35,78–85] (Table 2) testing the effects of radiotherapy after breast conservation surgery, three identified a low-risk group of patients that potentially might be spared radiotherapy.”
BackgroundChattopadhyay, N., Cai, Z., Pignol, J., Keller, B. M., Lechtman, E., Bendayan, R., & Reilly, R. M. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100207t · Cited by 151
Caudle, A. S., Yu, T., Tucker, S. L., Bedrosian, I., Litton, J. K., Gonzalez-Angulo, A. M., Hoffman, K. E., Meric‐Bernstam, F., Hunt, K. K., Buchholz, T. A., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3198 · Cited by 138
Gnerlich, J. L., Williams, R. T., Yao, K. A., Jaskowiak, N. T., & Kulkarni, S. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3395-6 · Cited by 136
“Adjuvant radiotherapy after breast conservation surgery for adenocarcinoma of the breast is standard of care.(33) It is plausible that clinicians approached the management of malignant phyllodes tumors in a similar manner and could also explain why one-quarter of the patients underwent lymph node sampling.”
BackgroundKrag, D. N., Julian, T. B., Harlow, S. P., Weaver, D. L., Ashikaga, T., Bryant, J., Single, R. M., & Wolmark, N. (2004) · Annals of Surgical Oncology · doi:10.1007/bf02523630 · Cited by 136
Self-citationChristiansen, P., Carstensen, S. L., Ejlertsen, B., Kroman, N. T., Offersen, B. V., Bodilsen, A., & Jensen, M. (2017) · Acta Oncologica · doi:10.1080/0284186x.2017.1403042 · Cited by 137
Financial Costs and Burden Related to Decisions for Breast Cancer Surgery
Greenup, R. A., Rushing, C. N., Fish, L. J., Campbell, B. M., Tolnitch, L., Hyslop, T., Peppercorn, J. M., Wheeler, S. B., Zafar, S. Y., Myers, E. R., et al. (2019) · Journal of Oncology Practice · doi:10.1200/jop.18.00796 · Cited by 142
Onitilo, A. A., Engel, J. M., Stankowski, R. V., & Doi, S. A. R. (2014) · Clinical Medicine & Research · doi:10.3121/cmr.2014.1245 · Cited by 137
Radiotherapy for invasive breast cancer in North America and Europe: Results of a survey
Ceilley, E., Jagsi, R., Goldberg, S. I., Grignon, L., Kachnic, L. A., Powell, S. N., & Taghian, A. G. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.05.069 · Cited by 134
Voltura, A., Tsangaris, T. N., Rosson, G. D., Jacobs, L. K., Flores, J. I., Singh, N., Argani, P., & Balch, C. M. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0102-0 · Cited by 133
Partial Breast Reconstruction: Current Perspectives
Losken, A., & Hamdi, M. (2009) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3181b179d2 · Cited by 133
“The reconstructive goals include (1) preservation of nipple viability, (2) reshaping of the breast mound, and (3) closure of dead space.”
BackgroundMethodInfluentialModern surgical treatment of breast cancer
Riis, M. L. H. (2020) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2020.06.016 · Cited by 133
Kwan, M. L., Ambrosone, C. B., Lee, M. M., Barlow, J., Krathwohl, S. E., Ergas, I. J., Ashley, C. H., Bittner, J. R., Darbinian, J. A., Stronach, K., et al. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9170-5 · Cited by 139
“Investigators interested in studies of breast cancer prognosis have generally ignored the potential role of dietary or other lifestyle factors and have instead focused on studies that examine modifications in adjuvant therapy, such as the National Surgical Adjuvant Breast Program [ 7 , 8], or the identification of mol…”
BackgroundChoosing Wisely: The American Society for Radiation Oncology’s Top 5 list
Hahn, C. A., Kavanagh, B. D., Bhatnagar, A. K., Jacobson, G. M., Lutz, S., Patton, C., Potters, L., & Steinberg, M. B. (2014) · Practical Radiation Oncology · doi:10.1016/j.prro.2014.06.003 · Cited by 130
Kirova, Y. M., Stoppa-Lyonnet, D., Savignoni, A., Sigal-Zafrani, B., Fabre, N., & Fourquet, A. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.02.037 · Cited by 129
Cao, D., Lin, C., Woo, S.-H., VANG, R. S., Tsangaris, T. N., & Argani, P. (2005) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000180448.08203.70 · Cited by 129
“Longterm follow-up studies have shown no difference in overall survival between these two approaches, so both are oncologically sound.(6,41) Patients who chose breast-conserving therapy do have an overall in-breast recurrence risk of approximately 1% per year.”
BackgroundDemirci, S., Nam, J., Hubbs, J. L., Nguyen, T., & Marks, L. B. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.11.016 · Cited by 129
dos Santos, G., Urban, C. A., Edelweiss, M. I. A., Zucca‐Matthes, G., de Oliveira, V. M., Arana, G. H., Iera, M., Rietjens, M., de Lima, R. S., Spautz, C., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4301-6 · Cited by 128
Jiang, X., & Xu, C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195772 · Cited by 137
“Still, up to one third of these patients will suffer distant recurrences, often after many years [11].”
BackgroundHarris, E. E. R., Christensen, V. J., Hwang, W., Fox, K. R., & Solin, L. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.056 · Cited by 128
Winters, Z., Benson, J. R., & Pusic, A. L. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181e623db · Cited by 128
Fisher, C. S., Martin-Dunlap, T. M., Ruppel, M. B., Gao, F., Atkins, J., & Margenthaler, J. A. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2525-x · Cited by 129
“Within the breast cancer literature, it is well established that survival outcomes are the same for lumpectomy and mastectomy despite increased recurrence rates for lumpectomy.(3) While a large amount of breast cancer research is directed at”
BackgroundCuttino, L. W., Keisch, M. E., Jenrette, J. M., Dragun, A. E., Prestidge, B. R., Quiet, C. A., Vicini, F. A., Rescigno, J., Wazer, D. E., Kaufman, S. A., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.09.046 · Cited by 126
“Acute skin reaction None 232 (48) Erythema 193 (40) Dry desquamation 39 (8) Moist desquamation 19 (4) Infection None 439 (91) Oral antibiotics required 29 (6) Intravenous antibiotics required 1 (<1) Surgical intervention 14 (3) Telangiectasia None 401 (83) <2 cm(2) and scant 58 (12) <2 cm(2) and dense 14 (3) >2 cm(2)…”
BackgroundRaine, R., Wong, W., Scholes, S., Ashton, C., Obichere, A., & Ambler, G. (2010) · BMJ · doi:10.1136/bmj.b5479 · Cited by 121
“and patients need to consider the benefits of avoiding a permanent stoma versus the potential risks of faecal urgency. For breast cancer, trials have shown no survival advantage for mastectomy over breast conserving surgery for tumours up to 5 cm.”
BackgroundWinzer, K., Sauerbrei, W., Braun, M., Liersch, T., Dunst, J., Guski, H., & Schumacher, M. C. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.10.007 · Cited by 125
Deutsch, M., Land, S. R., Begovič, M., Wieand, H. S., Wolmark, N., & Fisher, B. (2003) · Cancer · doi:10.1002/cncr.11655 · Cited by 125
Self-citationKennedy, B. F., McLaughlin, R. A., Kennedy, K. M., Chin, L., Wijesinghe, P., Curatolo, A., Tien, A., Ronald, M., Latham, B. I., Saunders, C. M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3694 · Cited by 124
Langhans, L., Jensen, M., Talman, M., Vejborg, I., Kroman, N. T., & Tvedskov, T. F. (2016) · JAMA Surgery · doi:10.1001/jamasurg.2016.4751 · Cited by 125
Ku, G. D. L. C., Karamchandani, M. M., Chambergo‐Michilot, D., Narvaez‐Rojas, A. R., Jonczyk, M. M., Príncipe-Meneses, F. S., Posawatz, D., Nardello, S. M., & Chatterjee, A. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-022-12133-8 · Cited by 129
Quality of life and satisfaction after breast cancer operation
Han, J., Grothuesmann, D., Neises, M., Hille, U., & Hillemanns, P. (2009) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-009-1302-y · Cited by 143
Torres–Roca, J. F., Fulp, W. J., Caudell, J. J., Servant, N., Bollet, M. A., van de Vijver, M. J., Naghavi, A. O., Harris, E. E. R., & Eschrich, S. A. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.06.021 · Cited by 127
“Classic prospective studies have demonstrated that post-lumpectomy RT to 50 Gy reduces local recurrences by 75% when compared to patients treated with lumpectomy alone (1).”
Loh, S. Y., & Nadia, A. (2015) · Breast Cancer: Targets and Therapy · doi:10.2147/bctt.s47012 · Cited by 116
“For less recognized problems faced by survivors of breast cancer, qualitative research identified “chemo-brain”, and attitudinal changes towards work.(7,51) Psycho-social rehabilitation and practical reminders were strategies proposed to improve cognitive function despite variations due to cultural differences.”
InfluentialJorns, J. M., Visscher, D. W., Sabel, M. S., Breslin, T. M., Healy, P. N., Daignaut, S., Myers, J. L., & Wu, A. J. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcp4iemxcj1gdts · Cited by 122
Fine, R. E., Gilmore, R. C., Dietz, J. R., Boolbol, S. K., Berry, M. P., Han, L. K., Kenler, A. S., Sabel, M. S., Tomkovich, K. R., VanderWalde, N. A., et al. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-021-10501-4 · Cited by 122
Holland, J. P., Normand, G., Ruggiero, A., Lewis, J. S., & Grimm, J. (2011) · Molecular Imaging · doi:10.2310/7290.2010.00047 · Cited by 122
Antonucci, J. V., Wallace, M. F., Goldstein, N. S., Kestin, L. L., Chen, P., Benitez, P., Dekhne, N. S., Martinez, A. A., & Vicini, F. A. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.08.025 · Cited by 121
Ueda, S., Tamaki, Y., Yano, K., Okishiro, N., Yanagisawa, T., Imasato, M., Shimazu, K., Kim, S. J., Miyoshi, Y., Tanji, Y., et al. (2007) · Surgery · doi:10.1016/j.surg.2007.10.006 · Cited by 122
“Number of patients Total 28 28 56 47 Tumor stage Tis 1 (4) 5 (18) 6 (11) 3 (6) T1 15 (54) 12 (43) 27 (48) 31 (66) T2 11 (39) 10 (36) 21 (38) 13 (28) T3 1 (4) 1 (4) 2 (4) 0 (0) Reconstruction# LDM 14 (50) 19 (68) 33 (59) DIEP 10 (36) 8 (29) 18 (32) TRAM 4 (14) 0 (0) 4 (7) Implant 0 (0) 1 (4) 1 (2) Axillary dissection$…”
Predictors of patients’ choices for breast-conserving therapy or mastectomy: a prospective study
Molenaar, S., Oort, F. J., Sprangers, M. A. G., Rutgers, E. J. T., Luiten, E. J. T., Mulder, J., & de Haes, J. C. J. M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601835 · Cited by 121
Metadata
- Authors
- Fisher, B., Anderson, S., Bryant, J., Margolese, R. G., Deutsch, M., Fisher, E. R., Jeong, J.-H., & Wolmark, N.
- Affiliations
- University of Pittsburgh (US)
- NSABP Foundation (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-10-17
- Volume
- 347
- Issue
- 16
- Pages
- 1233-1241
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2067420088
- Semantic Scholar
- 4468d9b99c6cf981372c46aebe6895549bc34b70
- Cited by
- 6,249
- References
- 28
- Citations by year
- 2026: 190 · 2025: 212 · 2024: 241 · 2023: 306 · 2022: 302 · 2021: 328 · 2020: 320 · 2019: 290 · 2018: 284 · 2017: 289 · 2016: 334 · 2015: 340 · 2014: 318 · 2013: 331 · 2012: 321
- FWCI
- 52.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (U10-CA37377, U10CA069651, U10CA037377, U10CA069974, U10 CA 69651, U10-CA-69974)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Keywords
- invasive breast cancer, total mastectomy, breast-conserving surgery, breast cancer radiotherapy, breast-conserving therapy, ipsilateral breast tumor recurrence, disease-free survival, overall survival, long-term outcomes
- MeSH terms
- Breast Neoplasms, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Neoplasm Invasiveness, Neoplasm Recurrence, Local, Mastectomy, Radical, Mastectomy, Segmental, Incidence, Survival Analysis, Randomized Controlled Trials as Topic, Neoplasms, Second Primary, Disease-Free Survival
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.